Biotechnology
Carl Icahn claims Illumina directors got extra insurance to close ‘disastrous’ $7.1 billion Grail deal
Carl Icahn on Friday alleged that Illumina‘s directors demanded extra personal liability insurance before the biotech company signed off on a $7.1 billion acquisition of cancer test developer Grail in 2021. The claim is the latest development in a brewing proxy fight between the activist investor and San Diego-based Illumina, who have been trading jabs […]
Read More
Pfizer’s Covid drug Paxlovid may reduce the risk of developing long Covid, study says
A prescription for Pfizers Paxlovid tablets outside of his apartment in Philadelphia, Pennsylvania on April 25, 2022. (Photo by Rachel Wisniewski/For the Washington Post) Rachel Wisniewski | The Washington Post | Getty Images People who take Pfizer‘s Covid antiviral treatment Paxlovid shortly after infection may reduce their risk of developing long Covid, regardless of their […]
Read More
Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD
A logo on the Sanofi exhibition space at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris, France June 15, 2022. Benoit Tessier | Reuters Shares of Sanofi and Regeneron both jumped by more than 6% on Thursday after the pharmaceutical companies released promising data showing their […]
Read More
Enjoy are living: TikTok CEO testifies in advance of Home committee as possible U.S. ban looms
(The stream is slated to commence at 10:00 a.m. ET. Be sure to refresh the web site if you do not see a video clip previously mentioned at that time.) TikTok CEO Shou Zi Chew will testify ahead of the Home Strength and Commerce Committee on Thursday morning as his business fights to stave off […]
Read More
FDA advisors vote against effectiveness of Biogen’s ALS drug for rare and aggressive form of the disease
A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration’s independent panel of advisors on Wednesday voted against the effectiveness of Biogen’s investigational ALS drug for a rare and aggressive form of the disease. The drug tofersen […]
Read More
FDA advisors reject Biogen’s ALS drug for rare and aggressive form of the disease
A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration’s independent panel of advisors on Wednesday declined to endorse accelerated approval of Biogen’s investigational ALS drug for a rare and aggressive form of the disease. The drug […]
Read More
View stay: Treasury Secretary Janet Yellen testifies at Senate hearing
(The stream is slated to begin at 2:30 pm ET. Remember to refresh the page if you do not see a online video above at that time.) Treasury Secretary Janet Yellen will testify just before the Senate Appropriations Committee Wednesday, where by she is most likely to deal with rough queries about the federal response […]
Read More
Moderna CEO Stephane Bancel defends fivefold price hike of Covid vaccine during Senate grilling
Moderna CEO Stephane Bancel on Wednesday defended the company’s plans to hike the price of its Covid shots fivefold, deflecting pressure at a Senate hearing to abandon the hike while taking barbs over his compensation. Moderna plans to increase the list price of its vaccine 400% to $130 when the shots are sold on the […]
Read More
Enjoy stay: Moderna CEO Stephane Bancel testifies in advance of Senate on Covid vaccine rate hike
(The hearing is scheduled to begin at 10 a.m. ET. Remember to refresh the web page if the video clip isn’t going to quickly enjoy at that time.) Moderna’s CEO Stephane Bancel is testifying Wednesday before the Senate well being committee on pricing of the company’s Covid-19 vaccine. The Boston biotech company designs to cost […]
Read More
Potentially deadly fungus candida auris is spreading at an ‘alarming rate,’ CDC says
A fungus that is often resistant to drugs has spread at an “alarming rate” through health-care facilities in the U.S., according to the Centers for Disease Control and Prevention. Candida auris is an emerging fungus that is serious and potentially fatal for hospitalized patients, particularly those with multiple medical problems. The fungus was first identified […]
Read More